RAC1 and cancer: Studies in cells indicated 43 reduced tumor growth, metastasis, and angiogenesis, with no apparent toxicity, indicating potential as a cancer therapeutic.82 Further modifications of the scaffold to bind deeper into the pocket yielded MBQ‐167 (44), which inhibited Rac1 activity in cells with an IC50 value of 103 nm.